0
0
Home » Pharmaceuticals

Thailand Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

The Thailand pharmaceutical market size was valued at $6.4 billion in 2021. Thailand’s pharmaceutical industry is Southeast Asia’s second-largest pharmaceutical market, after Indonesia. Thailand’s medical devices market size was valued at $6.3 billion in 2020. Thai medical services are well-known across the world owing to its robust medical foundation, which includes high-quality medical services, competent healthcare workers, and a diverse variety of internationally approved medical facilities.

The Thailand healthcare market research report is an essential source of information on the analysis of the healthcare, regulatory, and reimbursement landscape in Thailand. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

Thailand Pharmaceuticals Market Overview

Thailand Pharmaceuticals Market Overview

To gain more information on the Thailand pharmaceutical market forecast, download a free report sample

Thailand Medical Devices Market Overview

Thailand Medical Devices Market Overview

To gain more information on Thailand medical devices market forecast, download a free report sample

What are the market dynamics in the Thailand pharmaceuticals market?

The rise in non-communicable diseases like heart disease, diabetes, and cancer; the aging population; a universal healthcare system; the developing medical tourism business; greater foreign investments; and a favorable climate for clinical drug trials are contributing to the pharmaceutical market’s expansion.

The Thai government plans to implement various initiatives over 10 years (2016–25) to help Thailand reach the status of “Thailand, a Hub of Wellness and Medical Services” and develop into a medical center in four main areas: wellness, medical services, academics, and commodities. Moreover, the Thailand government’s supportive policies and BOI incentives will provide a suitable investment environment and opportunities for scientific studies and clinical R&D, which will result in significant growth in a wide range of medical and healthcare businesses.

Who are the key export and import partners in the Thailand pharmaceutical market?

The key export partners in the Thailand pharmaceutical market are Vietnam, Myanmar, Cambodia, Japan, and the Philippines. Vietnam accounts for the highest percentage of the export business. The key import partners in the Thailand pharmaceutical market are China, Germany, the US, Belgium, and India. China accounts for the highest percentage of the import business.

What are the key segments in the Thailand pharmaceuticals market?

The key segments in the Thailand pharmaceuticals market are generics, biologics, biosimilars, and over-the-counter (OTC).

Which are the major players in the Thailand pharmaceuticals market?

Some of the major players in the Thailand pharmaceuticals market are Pfizer, Sanofi, Novartis, GlaxoSmithKline (GSK), and F. Hoffmann-La Roche Ltd. (Roche).

Thailand Pharmaceuticals Market Analysis by Players

Thailand Pharmaceuticals Market Analysis by Players

To know more about major players in the pharmaceuticals market, download a free report sample

What are the market dynamics in the medical devices market of Thailand?

Thai medical services are well-known across the world owing to its robust medical foundation, which includes high-quality medical services, competent healthcare workers, and a diverse variety of internationally approved medical facilities.

Thailand’s policies give the strategic direction required to improve the country’s status as a regional medical hub. For instance, the government’s “eHealth plan 2017-36” aspires to establish Thailand as a worldwide medical hub. A solid foundation of health-related businesses, growing demand for health services, and favorable investment and tax benefits for medical device investors and importers, among other factors, together contribute to Thailand’s status as the “Medical Hub of Asia.“

What are the key segments in the Thailand medical devices market?

The key segments in the Thailand medical devices market are reagents & test kits, durable medical devices, and single-use devices. Single-use devices have the highest share among them in the market.

Thailand Medical Devices Market Analysis by Segments

Thailand Medical Devices Market Analysis by Segments

For more medical devices market segment insights, download a free report sample

Which are the major players in the Thailand medical devices market?

Some of the major players in the Thailand medical devices market are Fresenius, Abbott, GE Healthcare, Hoya, and Nipro.

Thailand Medical Devices Market Analysis by Players

Thailand Medical Devices Market Analysis by Players

To know more about the major market players in the medical devices market, download a free report sample

Thailand pharmaceuticals market overview

Market size (Year – 2021) $6.4 billion
Forecast period 2022-2026
Key segments Generics, Biologics, Biosimilars, and Over-the-Counter (OTC)
Key export partners Vietnam, Myanmar, Cambodia, Japan, and the Philippines
Key import partners China, Germany, the US, Belgium, and India
Major players Pfizer, Sanofi, Novartis, GlaxoSmithKline (GSK), and F. Hoffmann-La Roche Ltd. (Roche)

Thailand medical devices market overview

Market size (Year – 2020) $6.3 billion
Forecast period 2021 to 2025
Key segments Reagents & Test Kits, Durable Medical Devices, And Single-Use Devices
Major players Fresenius, Abbott, GE Healthcare, Hoya, and Nipro

 Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Thailand, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, Novartis, GSK, and Roche.
  • Profiles and SWOT analyses of the major players in the medical device market: Fresenius, Abbott, GE Healthcare, Hoya, and Nipro.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the Thailand healthcare market

Reasons to Buy

  • This report will enhance your decision-making capability by allowing you to:
  • Develop business strategies by understanding the trends shaping and driving Thailand’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Thailand’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents

1.1 List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights – Facts about the Thailand Healthcare Market

2.3 Key Highlights: Healthcare Startups in Thailand

2.4 Key Events: Thailand Healthcare Timeline, 2016–22

2.5 Key Events: Thailand Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020–22

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, Thailand, 2021

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Thailand

3.5 Pharmaceutical Market – Medical Tourism, Thailand

3.6 Pharmaceutical Market – Market Segments

3.7 Pharmaceutical Market – Market Segments, Generics, Thailand

3.8 Pharmaceutical Market – Market Segments, Biologics and Biosimilars, Thailand

3.9 Pharmaceutical Market – Market Segments, Over-the-Counter Medicines, Thailand

3.10 COVID-19 Epidemiology, Thailand

3.11 COVID-19 Impact and Developments in the Healthcare Market, Thailand

3.12 COVID-19 Clinical Trials Landscape, Thailand

3.13 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Thailand, 2018–22

6.2 Deal Analysis: Medical Device Market, Thailand, 2018–22

7. HealthTech Landscape

7.1 HealthTech Landscape, Thailand

7.2 HealthTech Deals Landscape, Thailand

7.3 Key HealthTech Deals, Thailand

7.4 Adoption of Technology in Healthcare, Thailand

7.5 Digital Regulations, Thailand

7.6 HealthTech Landscape: Benefits and Risks, Thailand

8. Market Access

8.1 Overview of Healthcare System, Thailand

8.2 Reimbursement Process, Thailand

8.3 Overview of Public and Private Insurance Providers, Thailand

8.4 Healthcare Spending and Prescription Drug Price Trend, Thailand

8.5 Pricing Policies, Thailand

8.6 Market Access: Key Events Timeline, Thailand, 2010–21

8.7 Regulatory Landscape, Thailand

8.7.1 Marketing Authorization for Pharmaceutical Products, Thailand

8.7.2 Marketing Authorization for Medical Devices, Thailand

8.7.3 Intellectual Property Rights, Patent, Thailand

8.7.4 Intellectual Property Rights, Trademark, Thailand

8.7.5 Clinical Trial Regulation Process, Thailand

8.7.6 Pharmaceutical Clinical Trials Landscape, Thailand

8.7.7 Medical Device Clinical Trials Landscape, Thailand

8.7.8 Pharmaceutical Export and Import, Thailand

8.7.9 Pharmaceutical Advertising Regulations, Thailand

8.7.10 Pharmacy Regulations, Thailand

8.7.11 Labeling and Packaging Regulations, Thailand

9. Country Healthcare Landscape

9.1 Thailand Healthcare Policy Highlights

9.2 Healthcare Facilities, Thailand

9.3 Healthcare Parameters, Thailand

9.4 Life Expectancy and Immunization Rate, Thailand

9.5 Environmental Health, Thailand

9.6 Healthcare Personnel, Thailand

9.7 Disease Burden, Thailand

9.8 Healthcare Expenditure, Thailand

10 Trade Associations, Thailand

11 Trade Fairs, Thailand

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

List of Tables

Table 1: Biopharmaceutical manufacturers, Thailand, 2022

Table 2: Biopharmaceutical products available in Thailand, 2022

Table 3: COVID-19 indicators (number of cases), Global and Thailand, 2022

Table 4: COVID-19-related travel restrictions, Thailand, 2020–22

Table 5: Available COVID-19 IVD products, Thailand, 2021–22

Table 6: COVID-19 vaccines trials, Thailand, 2022

Table 7: COVID-19 approved vaccines, Thailand, 2022

Table 8: Pipeline COVID-19 IVD products, Thailand, 2021-22

Table 9: Major product groups exported and imported by Thailand, 2018

Table 10: Key characteristics of the three major public health insurance schemes, Thailand, 2020

Table 11: Fees for pharmaceutical products, Thailand, 2022

Table 12: Medical devices classification, Thailand, 2022

Table 13: Patent registration fees, Thailand, 2022

Table 14: Patent maintenance fees, Thailand, 2022

Table 15: Trademark fees, Thailand, 2022

Table 16: Trade fairs, Thailand, 2022

List of Figures

Figure 1: Pharmaceutical market, revenue ($B), Thailand, 2013–21

Figure 2: Medical devices market, revenue ($B), Thailand, 2018–25

Figure 3: Healthcare start-ups in Thailand, 2022

Figure 4: Country profile, Thailand, 2021

Figure 5: Pharmaceutical market, revenue ($B), Thailand, 2013–21

Figure 6: Pharmaceutical market, revenue forecast ($B), Thailand, 2022–26

Figure 7: Pharmaceutical exports ($M), Thailand, 2014–21

Figure 8: Top export partners, Thailand, 2021

Figure 9: Pharmaceutical imports ($B), Thailand, 2014–21

Figure 10: Top import partners, Thailand, 2021

Figure 11: Pharmaceutical supply chain, Thailand, 2022

Figure 12: Major medical facilities, Thailand, 2020

Figure 13: Popular destinations for medical tourism, Thailand, 2020

Figure 14: Factors contributing to the growth of medical tourism, Thailand, 2022

Figure 15: Top surgical procedures offered in Thailand, 2020

Figure 16: Pharmaceutical market segments by % of sales, Thailand, 2019

Figure 17: OTC medicines market, major distribution channels ($M), Thailand, 2021

Figure 18: OTC market, revenue ($B), Thailand, 2013–21

Figure 19: OTC medicines market, major categories ($M), Thailand, 2021

Figure 20: COVID-19 cases, Thailand, 2020–22

Figure 21: COVID-19 deaths, Thailand, 2020–22

Figure 22: COVID-19 stringency index, Thailand, 2020–22

Figure 23: COVID-19 containment and health index, Thailand, 2020–22

Figure 24: COVID-19 fiscal stimulus timeline, Thailand, 2020–21

Figure 25: COVID-19 vaccine doses administration, number of vaccine doses administered, Thailand, 2022

Figure 26: COVID-19 vaccine booster doses administration, number of vaccine doses administered per 100 people, Thailand, 2021-22

Figure 27: COVID-19 clinical trials count by trial status, Thailand, 2021–22

Figure 28: COVID-19 clinical trials count by market categories, Thailand, 2021–22

Figure 29: Top COVID-19 clinical trials sponsors by trial count, Thailand, 2021–22

Figure 30: Medical devices market, revenue ($B), Thailand, 2018–25

Figure 31: Medical devices market, Thailand, major segments (%), 2020

Figure 32: Medical devices market, revenue ($B) of major companies, Thailand, 2021

Figure 33: Deal value and deal count, pharmaceutical market, Thailand, 2018–22

Figure 34: Deal value and deal count subtypes, pharmaceutical market, Thailand, 2018–22

Figure 35: Deal value and deal count, quarterly, pharmaceutical market, Thailand, 2018–22

Figure 36: Top therapy areas by deal value ($M), pharmaceutical market, Thailand, 2018–22

Figure 37: Top therapy areas by deal count, pharmaceutical market, Thailand, 2018–22

Figure 38: Deal value and deal count, medical devices market, Thailand, 2018–22

Figure 39: Deal value and deal count subtypes, medical devices market, Thailand, 2018–22

Figure 40: Deal value and deal count, quarterly, medical devices market, Thailand, 2018–22

Figure 41: Top equipment sectors by deal value ($M), medical devices market, Thailand, 2018–22

Figure 42: Top equipment sectors by deal count, medical devices market, Thailand, 2018–22

Figure 43: Components of eHealth strategy 2017-26, Thailand

Figure 44: Phases of eHealth strategy 2017-26, Thailand

Figure 45: Deal value ($M), Healthtech, Thailand, 2019–22

Figure 46: Deal count (no. of deals), Healthtech, Thailand, 2019–22

Figure 47: Digital government plan, Thailand, 2017-21

Figure 48: Organization of healthcare system, Thailand, 2022

Figure 49: Procedure of addition to national list of essential medicines, Thailand, 2022

Figure 50: Health financing flow, Thailand, 2022

Figure 51: OOP expenditure (% of current expenditure on health), Thailand, 2013–19

Figure 52: Annual rate of change (%), health price index, Thailand, 2013–21

Figure 53: Thailand FDA organizational structure, 2022

Figure 54: ASEAN common technical requirements (ACTR), Thailand, 2022

Figure 55: Drug registration and approval process, Thailand, 2022

Figure 56: Components of CSDT, Thailand, 2022

Figure 57: Medical devices pre-marketing controls, Thailand, 2022

Figure 58: Patent approval process, Thailand, 2022

Figure 59: Trademark approval process, Thailand, 2022

Figure 60: Clinical trial application requirements, Thailand, 2022

Figure 61: Pharmaceutical clinical trials count by trial status, Thailand, 2020–22

Figure 62: Pharmaceutical clinical trials count by indication, Thailand, 2020–22

Figure 63: Pharmaceutical clinical trials count by phase, Thailand, 2020–22

Figure 64: Top five pharmaceutical clinical trials sponsors by count, Thailand, 2020–22

Figure 65: Medical devices clinical trials count by trial status, Thailand, 2020–22

Figure 66: Medical devices clinical trials count by device category, Thailand, 2020–22

Figure 67: Medical devices clinical trials count by indication, Thailand, 2020–22

Figure 68:Top five medical devices clinical trials sponsors by count, Thailand, 2020–22

Figure 69: Pharmaceutical advertising approval process, Thailand, 2022

Figure 70: Number of hospitals, Thailand, 2012–21

Figure 71: Number of diagnostic equipment, Thailand, 2012–21

Figure 72: Number of public hospital beds (per 10,000 population), Thailand, 2012–20

Figure 73: Total number of hospital beds (per 10,000 population), Thailand, 2012–20

Figure 74: Number of private hospital beds (per 10,000 population), Thailand, 2012–20

Figure 75: Immunization rate (%), Thailand, 2013–19

Figure 76: Life expectancy at birth (years), Thailand, 2013–21

Figure 77: CO2 emissions (million tons), Thailand, 2013–19

Figure 78: PM2.5 (µg per m3), Thailand, 2013–21

Figure 79: Doctors (per 10,000 population), Thailand, 2012–20

Figure 80: Nurses (per 10,000 population), Thailand, 2012–20

Figure 81: Pharmacists (per 10,000 population), Thailand, 2012–20

Figure 82: Dentists (per 10,000 population), Thailand, 2012–20

Figure 83: Major causes of mortality (per 100,000 population), Thailand, 2019

Figure 84: Major causes of male mortality (per 100,000 population), Thailand 2019

Figure 85: Major causes of female mortality (per 100,000 population), Thailand, 2019

Figure 86: DALYs by major disease (per 100,000 population), Thailand, 2019

Figure 87: Healthcare expenditure as percentage of GDP (%), Thailand, 2013–21

Figure 88: Health expenditure share (% of total health spending), Thailand, 2013–21

Frequently Asked Questions

The pharmaceuticals market size in Thailand was valued at $6.4 billion in 2021.

The key segments in the Thailand pharmaceuticals market are generics, biologics, biosimilars, and over-the-counter (OTC).

The key export partners in the Thailand pharmaceuticals market are Vietnam, Myanmar, Cambodia, Japan, and the Philippines. The key import partners in the Thailand pharmaceutical market are China, Germany, the US, Belgium, and India.

Some of the major players in the Thailand pharmaceuticals market are Pfizer, Sanofi, Novartis, GlaxoSmithKline (GSK), and F. Hoffmann-La Roche Ltd. (Roche).

The medical devices market size in Thailand was valued at $6.3 billion in 2020.

The key segments in the Thailand medical devices market are reagents & test kits, durable medical devices, and single-use devices.

Some of the major players in the Thailand medical devices market are Fresenius, Abbott, GE Healthcare, Hoya, and Nipro.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports